Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma
2013
SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis
2011
Role of Heparanase in Radiation-Enhanced Invasiveness of Pancreatic Carcinoma
2011
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis
2010
p53: key conductor of all anti-acne therapies
2017
The heparanase/syndecan‐1 axis in cancer: mechanisms and therapies
2013
T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow
2017 StandoutNobel
Head and neck squamous cell carcinoma
2020 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes
2018 Standout
Kidney stones: pathophysiology and medical management
2006 Standout
Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer
2003
Emerging PEGylated drugs
2009
Recombinant Urate Oxidase (Rasburicase) in the Prophylaxis and Treatment of Tumor Lysis Syndrome
2004
The Chemical Biology of Aptamers
2009
ROS in cancer therapy: the bright side of the moon
2020 Standout
Colorimetric determination of urinary adenosine using aptamer-modified gold nanoparticles
2008
Advances in metal-induced oxidative stress and human disease
2011 Standout
Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and Management
2010
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Electronic Aptamer‐Based Sensors
2007
The Impact of PEGylation on Biological Therapies
2008
Rasburicase: future directions in tumor lysis management
2008
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Analytical applications of aptamers
2004
The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations
2015
Psoriasis
2021 Standout
Conformational Control of Energy Transfer: A Mechanism for Biocompatible Nanocrystal‐Based Sensors
2012 StandoutNobel
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
2006 Standout
Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome
2007
Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors
2011
Liquid chromatography, electrochromatography and capillary electrophoresis applications of DNA and RNA aptamers
2006
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
2010
Controlled drug delivery vehicles for cancer treatment and their performance
2018 Standout
Activation of metallothionein transcription by 4‐hydroxynonenal
2010
Aptamers as therapeutics
2010 Standout
Recent developments in the HPLC enantiomeric separation using chiral selectors identified by a combinatorial strategy
2006
Functionalized nanoparticles for liquid atmospheric pressure matrix‐assisted laser desorption/ionization peptide analysis
2004
Extracellular matrix structure
2015 Standout
A Comparison of Inpatient Length of Stay and Costs Among Patients with Hematologic Malignancies (Excluding Hodgkin Disease) Associated with and Without Acute Renal Failure
2008
Adaptive Recognition of Small Molecules by Nucleic Acid Aptamers through a Label‐Free Approach
2007
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase
2005
Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms
2018
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Pacritinib: a new agent for the management of myelofibrosis?
2015
Colorimetric Biosensing Using Smart Materials
2011
Surface immobilization methods for aptamer diagnostic applications
2007
Spontaneous intracerebral hemorrhage in critically ill patients: incidence over six years and associated factors
1999
Sickle-cell disease
2010 Standout
Fluorescent-labeled single-strand ATP aptamer DNA: Chemo- and enantio-selectivity in sensing adenosine
2007
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
The Janus Kinase 2 Inhibitor Fedratinib Inhibits Thiamine Uptake: A Putative Mechanism for the Onset of Wernicke’s Encephalopathy
2014
<p>Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics</p>
2019 Standout
Rasburicase (Elitek): A Novel Agent for Tumor Lysis Syndrome
2005
A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis
2016
Site-specific chemical protein conjugation using genetically encoded aldehyde tags
2012 StandoutNobel
Disseminated Intravascular Coagulation
1999 Standout
Optical Sensors Based on Hybrid DNA/Conjugated Polymer Complexes
2004
The molecular characterization and clinical management of multiple myeloma in the post-genome era
2009
Aptamers come of age – at last
2006
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
2012 Standout
The Involvement of Metallothioneins in Mitochondrial Function and Disease
2010
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Electrochemical Biosensors - Sensor Principles and Architectures
2008 Standout
Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
2009
Functional Nucleic Acid Sensors
2009 Standout
Conjugated Polyelectrolyte-Sensitized Fluorescent Detection of Thrombin in Blood Serum Using Aptamer-Immobilized Silica Nanoparticles as the Platform
2009
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Aptamer-Based Enantioselective Competitive Binding Assay for the Trace Enantiomer Detection
2007
JAK2 inhibitors for myeloproliferative neoplasms: what is next?
2017
Sebum lipids influence macrophage polarization and activation
2017
The Tumor Lysis Syndrome
2011 Standout
Targeting the JAK/STAT pathway in solid tumors
2020
Supramolecular Chirality in Self-Assembled Systems
2015 Standout
Regulation of zinc homeostasis by inducible NO synthase-derived NO: Nuclear metallothionein translocation and intranuclear Zn2+release
2003
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
2008 Standout
Dephosphorylation of d -Peptide Derivatives to Form Biofunctional, Supramolecular Nanofibers/Hydrogels and Their Potential Applications for Intracellular Imaging and Intratumoral Chemotherapy
2013
Tracking plasma cell differentiation and survival
2013
Localized Surface Plasmon Resonance Sensors
2011 Standout
Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation
2012
Functional π-Gelators and Their Applications
2014 Standout
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Momelotinib treatment‐emergent neuropathy: prevalence, risk factors and outcome in 100 patients with myelofibrosis
2014
Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions
2016 Standout
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
2020
Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma
2016
Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome
2010
Helical Polymers: Synthesis, Structures, and Functions
2009 Standout
Pathogenic Long-Lived Plasma Cells and Their Survival Niches in Autoimmunity, Malignancy, and Allergy
2012
Functional Aptamers and Aptazymes in Biotechnology, Diagnostics, and Therapy
2007
Chemical Sensors Based on Amplifying Fluorescent Conjugated Polymers
2007 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy
2012 Standout
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
In Vitro Evolution of Functional DNA Using Capillary Electrophoresis
2003
Efficient Separation of Enantiomers Using Stereoregular Chiral Polymers
2015
Metallothionein protects against oxidative stress-induced lysosomal destabilization
2006
Multiple Myeloma
2011 Standout
Cancer-associated stroke: Pathophysiology, detection and management (Review)
2019
Optically Active Polymers for Chiral Separation
2004
Therapy for myeloproliferative neoplasms: when, which agent, and how?
2014
A Mechanistic Study of Enantiomeric Separation with Vancomycin and Balhimycin as Chiral Selectors by Capillary Electrophoresis. Dimerization and Enantioselectivity
2004
The Use of N‐Type Ligands in the Enantioselective Liquid–Liquid Extraction of Underivatized Amino Acids
2010 StandoutNobel
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Taurine Boosts Cellular Uptake of Small d -Peptides for Enzyme-Instructed Intracellular Molecular Self-Assembly
2015
DNA-Driven Focusing for Protein−DNA Binding Assays Using Capillary Electrophoresis
2005
Works of Éric Jourdan being referenced
Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions
2013
Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study).
2002
Study of tryptophan enantiomer binding to a teicoplanin-based stationary phase using the perturbation technique
2003
Zinc resistance impairs sensitivity to oxidative stress in hela cells: protection through metallothioneins expression
2001
Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic component
1995
Effects of cadmium and zinc on solar-simulated light-irradiated cells: potential role of zinc-metallothionein in zinc-induced genoprotection
2002
Role of the vancomycin-ristocetin heterodimerization on the enantioselectivity of d,l-tryptophan and d,l-dansyl tryptophan
2003
Severe Autoimmune Hemolytic Anemia Following Rituximab Therapy in a Patient with a Lymphoproliferative Disorder
2003
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study
2017
APRIL and TACI interact with syndecan‐1 on the surface of multiple myeloma cells to form an essential survival loop
2009
Results of the PERSIST-1 phase III study of pacritinib (PAC) versus best available therapy (BAT) in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF), or post-essential thrombocythemia-myelofibrosis (PET-MF).
2015
Preliminary results of a phase II study of rituximab (R), gemcitabine (Gem), oxaliplatin (Ox) plus enzastaurin (ENZ) followed by ENZ maintenance as salvage regimen for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
2010
Results of the PERSIST-1 phase III study of pacritinib (PAC) versus best available therapy (BAT) in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF), or post-essential thrombocythemia-myelofibrosis (PET-MF).
2015
Efficacy and Safety of Rasburicase (recombinant urate oxidase) for the Prevention and Treatment of Hyperuricemia During Induction Chemotherapy of Aggressive Non-Hodgkin’s Lymphoma: Results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) Study
2003
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis
2015
Results Of a Randomized, Double-Blind, Placebo-Controlled Phase III Study (JAKARTA) Of The JAK2-Selective Inhibitor Fedratinib (SAR302503) In Patients With Myelofibrosis (MF)
2013
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma
2007
A DNA Aptamer as a New Target-Specific Chiral Selector for HPLC
2003
Immobilized DNA Aptamers as Target-Specific Chiral Stationary Phases for Resolution of Nucleoside and Amino Acid Derivative Enantiomers
2004